Cancer Control


  • AG013:  A Phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of topically-applied AG013 for the attenuation of oral mucositis in subjects with cancers of the head and neck receiving concomitant chemoradiation therapy
  • A15804: Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

  • A prospective observational study to estimate the incidence of Febrile Neutropenia (FN) among subjects with non-myeloid malignancies at high risk for FN and receiving Neulasta Onpro kit or other physician choice options for prophylaxis of FN

  • URCC-18007: Randomized Placebo Controlled Trial of Bupropion For Cancer Related Fatigue

  • For more information, contact Lauren Key, RN, BSN at 360-788-8238